| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |